Emergency green channel information management method and system

Abstract

The invention discloses an emergency green channel information management method and system, and relates to the technical field of big data. The method configures an outpatient injury and disease drug database and an emergency injury and disease drug database; obtains a timed reading instruction for drug sales information, and associates it with the emergency injury and disease drug database; searches whether the emergency injury and disease drug database has first key drug sales information; when the information is available, obtains first key drug sales information of a first preset type from the emergency injury and disease drug database and associates it with the last column of a data table of the outpatient injury and disease drug database; searches whether the outpatient injury and disease drug database has second key drug sales information, and when the information is available, gives an early warning of second key drug sales information of a second preset type in the outpatient injury and disease drug database, so as to effectively improve the quality of emergency channel management, realize intelligent and automatic monitoring of emergency channel management, reduce the burden on personnel, and realize big data management of emergency channel.

Description

Technical Field

[0001] The present invention relates to the field of big data technology, and in particular to an emergency green channel information management method and system. Background Art

[0002] At a time when big data technology is highly developed, building a smart drug emergency channel system based on a big data environment is an important direction for the development of modern emergency channels. Existing technologies can collect different data from drugs and derive the impact of different drug data on different injuries and diseases, so that the recovery period of people with different injuries and diseases under the current drug factors can be accurately calculated. Patients do not need to try different drugs. The best and most suitable drug can be selected by detecting changes in the condition at the time point, which can effectively avoid the impact of human judgment errors on drug sales.

[0003] However, the smart emergency channel system should not only be used for the detection of emergency injuries and diseases, but also be used to help managers identify and solve injury diagnosis, sales, after-sales and provide patients with intelligent emergency channel risk assessment. Only in this way can a complete smart emergency channel and ordinary system be formed. In order to solve the above problems, we propose an emergency green channel information management method and system. Summary of the invention

[0004] To achieve the above objectives, this application provides the following technical solutions:

[0005] According to a first aspect of the present invention, the present invention claims protection for an emergency green channel information management method, comprising:

[0006] Configure outpatient injury and disease drug database and emergency injury and disease drug database;

[0007] Obtaining a timed reading instruction for drug sales information, and associating the drug sales information with an emergency injury and disease drug database;

[0008] Searching the emergency disease and injury drug database for first key drug sales information according to a first preset period, wherein the first key drug sales information includes the drug sales information in the emergency disease and injury drug database that meets the first preset relationship;

[0009] When the emergency disease and injury drug database has the first key drug sales information, the first key drug sales information of a first preset type number is obtained from the emergency disease and injury drug database and associated with the last column of the data table of the outpatient disease and injury drug database;

[0010] Searching the outpatient injury and disease drug database for second key drug sales information according to a second preset period, wherein the second key drug sales information includes the first key drug sales information in the outpatient injury and disease drug database that meets the second preset relationship;

[0011] When the outpatient injury and illness medicine database contains the second key medicine sales information, an early warning of the second key medicine sales information of a second preset type number in the outpatient injury and illness medicine database is given.

[0012] Furthermore, the timed reading instruction for obtaining drug sales information associates the drug sales information with an emergency injury and disease drug database, including:

[0013] Obtaining a timed reading instruction for the drug sales information;

[0014] Performing sales volume analysis on the drug sales information based on the timing information of the drug sales information in the emergency injury and disease drug database to obtain the popularity of the drug sales information in the emergency injury and disease drug database;

[0015] The drug sales information is associated with the corresponding popularity in the emergency injury and illness drug database.

[0016] Furthermore, the emergency green channel information management method also includes:

[0017] Obtaining a read instruction for newly added drug sales information, and associating the newly added drug sales information with an outpatient injury and disease drug database;

[0018] Searching the outpatient injury and disease drug database for the second preset period to determine whether the second key drug sales information exists, wherein the second key drug sales information also includes the newly added drug sales information in the outpatient injury and disease drug database that meets the second preset relationship;

[0019] When the outpatient injury and disease drug database has the second key drug sales information, an early warning of the second key drug sales information of a second preset type number in the outpatient injury and disease drug database is given;

[0020] The instruction to obtain the newly added drug sales information and associate the newly added drug sales information with the outpatient injury and disease drug database includes:

[0021] Obtaining a read instruction for the newly added drug sales information;

[0022] Based on the timing information of the first key drug sales information in the outpatient injury and disease drug database, the sales volume of the newly added drug sales information is analyzed to obtain the popularity of the newly added drug sales information in the outpatient injury and disease drug database;

[0023] The newly added drug sales information is associated with the corresponding popularity in the outpatient injury and illness drug database.

[0024] Further, when the outpatient injury and disease drug database has the second key drug sales information, giving an early warning of the second key drug sales information of a second preset type number in the outpatient injury and disease drug database includes:

[0025] When the outpatient injury and illness drug database contains the second key drug sales information, determining whether the warning is excessively issued;

[0026] When the warning is not over-issued, obtaining the number of warning scheme types to be issued for the warning, and determining whether the second preset number of types is greater than the number of warning scheme types to be issued;

[0027] When the second preset type number is not greater than the number of types of the to-be-issued warning schemes, a warning is given for the sales information of the second key drugs of the second preset type number in the outpatient injury and disease drug database;

[0028] When the second preset type number is greater than the number of types of the warning schemes to be issued, the second preset type number is set to be the same as the number of types of the warning schemes to be issued, and a warning is given to the second key drug sales information of the second preset type number set in the outpatient injury and disease drug database;

[0029] When the emergency injury and disease drug database has the first key drug sales information, the first preset type number of the first key drug sales information is obtained from the emergency injury and disease drug database and the last column of the data table associated with the outpatient injury and disease drug database includes:

[0030] When the emergency injury and disease drug database has the first key drug sales information, determining whether the outpatient injury and disease drug database has a free position;

[0031] When the outpatient injury and disease drug database has a vacant position, the first key drug sales information of the first preset type number is obtained from the emergency injury and disease drug database and associated with the last column of the data table of the outpatient injury and disease drug database;

[0032] When the outpatient injury and disease drug database has no free space, determining whether the outpatient injury and disease drug database has deletable drug sales information;

[0033] When the outpatient injury and illness drug database has the deletable drug sales information, the deletable drug sales information is deleted from the outpatient injury and illness drug database, and the first key drug sales information of the first preset type number is obtained from the emergency injury and illness drug database and associated with the last column of the data table of the outpatient injury and illness drug database.

[0034] Furthermore, the decision of whether the outpatient injury and illness drug database contains deletable drug sales information includes:

[0035] Sending a feedback instruction to the first key drug sales information and / or the newly added drug sales information in the outpatient injury and illness drug database;

[0036] If the first key drug sales information and / or the newly added drug sales information does not respond to the feedback instruction within the third preset period, the first key drug sales information and / or the newly added drug sales information that does not respond to the feedback instruction is determined to be deletable drug sales information;

[0037] or;

[0038] If the first key drug sales information and / or the newly added drug sales information cancels the scheduled reading instruction, it is determined that the first key drug sales information and / or the newly added drug sales information that cancels the scheduled reading instruction is deletable drug sales information.

[0039] According to a second aspect of the present invention, the present invention claims protection for an emergency green channel information management system, comprising:

[0040] Configuration device, used for configuring outpatient injury and disease drug database and emergency injury and disease drug database;

[0041] The first acquisition device is used to obtain a timed reading instruction for drug sales information, and associate the drug sales information with an emergency injury and disease drug database;

[0042] A first search device is used to search the emergency injury and disease drug database for first key drug sales information according to a first preset period, wherein the first key drug sales information includes the drug sales information in the emergency injury and disease drug database that meets the first preset relationship;

[0043] The first analyzing means is used for obtaining the first preset number of types of the first key drug sales information from the emergency injury and disease drug database and associating the last column of the data table of the outpatient injury and disease drug database when the emergency injury and disease drug database has the first key drug sales information;

[0044] A second search device is used to search the outpatient injury and disease drug database for second key drug sales information according to a second preset period, wherein the second key drug sales information includes the first key drug sales information in the outpatient injury and disease drug database that meets the second preset relationship;

[0045] The second analyzing device is used for giving an early warning of the second key drug sales information of a second preset type number in the outpatient injury and disease drug database when the outpatient injury and disease drug database contains the second key drug sales information.

[0046] Furthermore, the first acquisition device includes:

[0047] A first acquisition module, used for acquiring a timing reading instruction of the drug sales information;

[0048] A first sales analysis module, configured to perform sales analysis on the drug sales information based on the timing information of the drug sales information in the emergency injury and disease drug database, and obtain the popularity of the drug sales information in the emergency injury and disease drug database;

[0049] The first placement module is used to associate the drug sales information with the corresponding heat in the emergency injury and illness drug database.

[0050] Furthermore, the emergency green channel information management system also includes:

[0051] The second acquisition device is used to obtain a read instruction for newly added drug sales information, and associate the newly added drug sales information with an outpatient injury and disease drug database;

[0052] A third search device is used to search the outpatient injury and disease drug database for the second key drug sales information according to the second preset period, wherein the second key drug sales information also includes the newly added drug sales information in the outpatient injury and disease drug database that meets the second preset relationship;

[0053] The third analysis device is used to give an early warning of the sales information of the second key drugs of a second preset type in the outpatient injury and disease drug database when the sales information of the second key drugs is present in the outpatient injury and disease drug database;

[0054] The second acquisition device includes:

[0055] A second acquisition module, used for acquiring a reading instruction of the newly added drug sales information;

[0056] A second sales analysis module is used to perform sales analysis on the newly added drug sales information based on the timing information of the first key drug sales information in the outpatient injury and disease drug database to obtain the popularity of the newly added drug sales information in the outpatient injury and disease drug database;

[0057] The second placement module is used to associate the newly added drug sales information with the corresponding popularity in the outpatient injury and illness drug database.

[0058] Furthermore, the third analysis device comprises:

[0059] A first decision module is used to decide whether the warning is excessively issued when the outpatient injury and disease drug database contains the second key drug sales information;

[0060] A second decision module is used for obtaining the number of types of warning schemes to be issued for the warning when the warning is not over-issued, and deciding whether the second preset number of types is greater than the number of types of warning schemes to be issued;

[0061] A first issuing module, configured to issue an early warning of the sales information of the second key drugs of the second preset type number in the outpatient injury and disease drug database when the second preset type number is not greater than the type number of the early warning scheme to be issued;

[0062] A second issuing module is used for setting the second preset type number to be the same as the number of the warning scheme types to be issued when the second preset type number is greater than the number of the warning scheme types to be issued, and giving a warning of the sales information of the second key drug of the second preset type number set in the outpatient injury and disease drug database;

[0063] The first analysis device comprises:

[0064] A third decision module is used to decide whether the outpatient injury and disease drug database has a vacant position when the emergency injury and disease drug database has the first key drug sales information;

[0065] A first analysis module is used for obtaining the first key drug sales information of the first preset type number from the emergency injury and disease drug database and associating it with the last column of the data table of the outpatient injury and disease drug database when the outpatient injury and disease drug database has a vacant position;

[0066] A fourth decision module, for deciding whether there is deletable drug sales information in the outpatient injury and disease drug database when the outpatient injury and disease drug database does not have any free space;

[0067] The second analysis module is used for deleting the deletable drug sales information from the outpatient injury and disease drug database when the outpatient injury and disease drug database has the deletable drug sales information, and obtaining the first key drug sales information of the first preset type number from the emergency injury and disease drug database and associating it with the last column of the data table of the outpatient injury and disease drug database.

[0068] Furthermore, the fourth decision module includes:

[0069] Sending a feedback instruction to the first key drug sales information and / or the newly added drug sales information in the outpatient injury and illness drug database;

[0070] If the first key drug sales information and / or the newly added drug sales information does not respond to the feedback instruction within the third preset period, the first key drug sales information and / or the newly added drug sales information that does not respond to the feedback instruction is determined to be deletable drug sales information;

[0071] or;

[0072] If the first key drug sales information and / or the newly added drug sales information cancels the scheduled reading instruction, it is determined that the first key drug sales information and / or the newly added drug sales information that cancels the scheduled reading instruction is deletable drug sales information.

[0073] The emergency green channel information management method disclosed in the present invention configures an outpatient injury and disease drug database and an emergency injury and disease drug database; obtains a timed reading instruction for drug sales information and associates it with the emergency injury and disease drug database; searches whether the emergency injury and disease drug database has first key drug sales information; if so, obtains first key drug sales information of a first preset type number from the emergency injury and disease drug database and associates it with the last column of a data table of the outpatient injury and disease drug database; searches whether the outpatient injury and disease drug database has second key drug sales information, and if so, gives an early warning of second key drug sales information of a second preset type number in the outpatient injury and disease drug database, which can effectively improve the quality of emergency channel management, realize intelligent and automated monitoring of emergency channel management, effectively reduce the burden on personnel, and realize big data management of emergency channel. BRIEF DESCRIPTION OF THE DRAWINGS

[0074] Figure 1 A flowchart of the emergency green channel information management method claimed in the embodiment of the present application;

[0075] Figure 2 This is a structural module diagram of the emergency green channel information management system requested for protection in the embodiments of the present application. DETAILED DESCRIPTION

[0076] The following will be combined with the drawings in the embodiments of the present application to clearly and completely describe the technical solutions in the embodiments of the present application. Obviously, the described embodiments are only part of the embodiments of the present application, not all of the embodiments. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of this application.

[0077] The terms "first", "second" and "third" in this application are only used for descriptive purposes and cannot be understood as indicating or implying relative importance or implicitly indicating the number of types of technical features indicated. Thus, the features defined as "first", "second" and "third" may explicitly or implicitly include at least one of the features. In the description of this application, the meaning of "multiple" is at least two, such as two, three, etc., unless otherwise clearly and specifically defined. All directional indications (such as up, down, left, right, front, back...) in the embodiments of this application are only used to explain the relative thermal relationship, movement, etc. between the components under a certain specific posture (as shown in the accompanying drawings). If the specific posture changes, the directional indication also changes accordingly. In addition, the terms "including" and "having" and any of their variations are intended to cover non-exclusive inclusions. For example, a process, method, system, product or device that includes a series of steps or modules is not limited to the listed steps or modules, but optionally also includes steps or modules that are not listed, or optionally also includes other steps or modules inherent to these processes, methods, products or devices.

[0078] Reference to "embodiments" herein means that a particular feature, structure, or characteristic described in conjunction with the embodiments may be included in at least one embodiment of the present application. The various occurrences of the phrase in the specification do not necessarily all refer to the same embodiment, nor are they independent or alternative embodiments that are mutually exclusive with other embodiments. It is explicitly and implicitly understood by those skilled in the art that the embodiments described herein may be combined with other embodiments.

[0079] Figure 1 A schematic diagram of the process of emergency green channel information management provided in an embodiment of this specification, the method may include:

[0080] S101: Configure the outpatient injury and disease drug database and the emergency injury and disease drug database;

[0081] In a specific implementation of this specification, the information management solution for the emergency green channel includes a drug sales information scheduling system, which includes an Oracle server and multiple drug sales information pools, and the multiple drug sales information pools include an outpatient injury and disease drug database and an emergency injury and disease drug database.

[0082] Among them, outpatient injuries include but are not limited to: various chronic diseases, skin injuries, minor injuries;

[0083] Emergency injuries and illnesses include, but are not limited to: various acute illnesses and serious injuries;

[0084] S102: Obtaining a timed reading instruction for drug sales information, and associating the drug sales information with an emergency injury and disease drug database;

[0085] Optionally, the timed reading instruction for obtaining drug sales information, which associates the drug sales information with an emergency injury and disease drug database, includes:

[0086] Obtaining a timed reading instruction for the drug sales information;

[0087] Performing sales volume analysis on the drug sales information based on the timing information of the drug sales information in the emergency injury and disease drug database to obtain the popularity of the drug sales information in the emergency injury and disease drug database;

[0088] The drug sales information is associated with the corresponding popularity in the emergency injury and illness drug database.

[0089] In a specific implementation of the present specification, when the Oracle server obtains the timed reading instruction of the drug sales information, the drug sales information and the timing information can be obtained according to the timed reading instruction, and the timing information includes the timed reading cycle. The drug sales information is queued by the timed reading cycle of the drug sales information in the emergency injury and disease drug database, and the popularity of the drug sales information in the emergency injury and disease drug database is obtained, and the drug sales information is associated with the corresponding popularity in the emergency injury and disease drug database. For example: in the emergency injury and disease drug database, the timed reading cycle of drug sales information A is 10 minutes, and the timed reading cycle of drug sales information B is 20 minutes. The timed reading cycle of drug sales information C is 15 minutes. By comparing the timed reading cycle, it is obtained that 15 minutes is between 10 minutes and 20 minutes, and it is obtained that drug sales information C should be placed between drug sales information A and drug sales information B in the emergency injury and disease drug database. Through sales analysis, the popularity of drug sales information in the emergency injury and disease drug database can be accurately obtained, and the efficiency and accuracy of drug sales information processing can be improved.

[0090] S103: searching the emergency disease medicine database for first key medicine sales information according to a first preset period, wherein the first key medicine sales information includes the medicine sales information in the emergency disease medicine database that meets the first preset relationship;

[0091] S104: when the emergency disease and injury drug database has the first key drug sales information, obtain the first preset type number of the first key drug sales information from the emergency disease and injury drug database and associate it with the last column of the data table of the outpatient disease and injury drug database;

[0092] In the specific implementation manner of this specification, the first preset period is set according to actual needs, and can also be an empirical value, or it can be the result of statistical analysis. The first preset relationship can be used to decide whether the timed reading period of drug sales information is within the preset period. Specifically, it can be: through statistics, it can be obtained that the optimal value of the first preset period is 30 minutes, and the decision drug sales information is read every 30 minutes. The current period is 10 minutes. Whether the timed reading period in the emergency injury drug database is within 10 minutes, it is determined whether the drug sales information meets the first preset relationship, and the emergency injury drug database has the first key drug sales information.

[0093] When there is first-priority drug sales information in the emergency injury and disease drug database, all first-priority drug sales information that meets the first preset relationship is obtained, or, based on the capacity of the outpatient injury and disease drug database, the first-priority drug sales information of the first preset type is obtained, and the first-priority drug sales information obtained is associated with the last column of the data table of the outpatient injury and disease drug database. Through this step, the first preset relationship can be set according to actual needs to improve the efficiency of drug sales information processing;

[0094] The first preset type number is the number of emergency injury and illness drug types pre-stored in the database.

[0095] S105: searching the outpatient injury and disease drug database for second key drug sales information according to a second preset period, wherein the second key drug sales information includes the first key drug sales information in the outpatient injury and disease drug database that meets the second preset relationship;

[0096] S106: When the outpatient injury and disease drug database contains the second key drug sales information, an early warning of the second key drug sales information of a second preset type number in the outpatient injury and disease drug database is given.

[0097] The second preset type number is the number of outpatient injury and illness drug types pre-stored in the database.

[0098] In the specific implementation of this specification, the second preset period is set according to actual needs, and can also be an empirical value or the result of statistical analysis. The second preset relationship can be whether the timed reading period of the decision-making first key drug sales information is within the current preset period. Specifically, it can be: through statistics, it can be obtained that the optimal value of the second preset period is 1 minute, and the decision-making drug sales information is read every 1 minute. The current period is 10 minutes. Whether the timed reading period in the emergency injury and disease drug database is within 10 minutes, it is determined whether the drug sales information meets the second preset relationship, and the outpatient injury and disease drug database has the second key drug sales information.

[0099] When there is second-key drug sales information in the outpatient injury and disease drug database, all second-key drug sales information that meets the second preset relationship is obtained, or, according to the capacity of the warning heat, the second-key drug sales information of the second preset type number is obtained, and the obtained second-key drug sales information is associated with the warning heat. Through this step, the second preset relationship can be set according to actual needs to improve the efficiency of drug sales information processing.

[0100] Optionally, the method further includes:

[0101] Obtaining a read instruction for newly added drug sales information, and associating the newly added drug sales information with an outpatient injury and disease drug database;

[0102] Searching the outpatient injury and disease drug database for the second preset period to determine whether the second key drug sales information exists, wherein the second key drug sales information further includes the newly added drug sales information in the outpatient injury and disease drug database that meets the second preset relationship;

[0103] When the outpatient injury and illness medicine database contains the second key medicine sales information, an early warning of the second key medicine sales information of a second preset type number in the outpatient injury and illness medicine database is given.

[0104] Optionally, the instruction for obtaining the newly added drug sales information and associating the newly added drug sales information with the outpatient injury and disease drug database includes:

[0105] Obtaining a read instruction for the newly added drug sales information;

[0106] Based on the timing information of the first key drug sales information in the outpatient injury and disease drug database, the sales volume of the newly added drug sales information is analyzed to obtain the popularity of the newly added drug sales information in the outpatient injury and disease drug database;

[0107] The newly added drug sales information is associated with the corresponding popularity in the outpatient injury and illness drug database.

[0108] In the specific implementation of this specification, a read instruction for queue-jumping drug sales information (i.e., temporarily added drug sales information) is obtained, and sales analysis is performed on the newly added drug sales information according to the timed reading cycle of the first key drug sales information in the outpatient injury and disease drug database, and the heat of the newly added drug sales information in the outpatient injury and disease drug database is obtained, and the newly added drug sales information is associated with the correct heat. Through sales analysis, the heat of drug sales information in the emergency injury and disease drug database can be accurately obtained, and the efficiency and accuracy of drug sales information processing can be improved.

[0109] The second preset relationship may be used to determine whether a timing reading cycle for newly added drug sales information is within a preset cycle of the current cycle.

[0110] When there is second-key drug sales information in the outpatient injury and disease drug database, all second-key drug sales information that meets the second preset relationship is obtained, or, according to the capacity of the warning heat, the second-key drug sales information of the second preset type number is obtained, and the obtained second-key drug sales information is associated with the warning heat. Through this step, the second preset relationship can be set according to actual needs to improve the efficiency of drug sales information processing.

[0111] Optionally, when the outpatient injury and disease drug database contains the second key drug sales information, giving an early warning of the second key drug sales information of a second preset type in the outpatient injury and disease drug database includes:

[0112] When the outpatient injury and illness drug database contains the second key drug sales information, determining whether the warning is excessively issued;

[0113] When the warning is not over-issued, obtaining the number of warning scheme types to be issued for the warning, and determining whether the second preset number of types is greater than the number of warning scheme types to be issued;

[0114] When the second preset type number is not greater than the number of types of the to-be-issued warning schemes, a warning is given for the sales information of the second key drugs of the second preset type number in the outpatient injury and disease drug database;

[0115] When the second preset type number is greater than the number of warning scheme types to be issued, the second preset type number is set to be the same as the number of warning scheme types to be issued, and a sales information warning of the second key drug of the second preset type number set in the outpatient injury and illness drug database is given.

[0116] In a specific implementation manner of the present specification, when there is second key drug sales information in the outpatient injury and disease drug database, a decision is made as to whether the warning is over-issued; when the warning is not over-issued, the number of warning scheme types to be issued for the warning is obtained, and a decision is made as to whether the second preset type number is greater than the number of warning scheme types to be issued; when the second preset type number is not greater than the number of warning scheme types to be issued, a warning for the second key drug sales information of the second preset type number in the outpatient injury and disease drug database is given; when the second preset type number is greater than the number of warning scheme types to be issued, the second preset type number is set to be the same as the number of warning scheme types to be issued, and a warning for the second key drug sales information of the second preset type number set in the outpatient injury and disease drug database is given. For example: the warning heat is 10, when there are currently 8 drug sales information with warnings, the warnings are not over-issued, and there are 2 warning plans to be issued, whether the second preset type number is greater than 2, when the second preset type number is 1 or 2, directly give 1 or 2 second key drug sales information warnings, when the second preset type number is 3, set the second preset type number to 2, and give 2 second key drug sales information warnings.

[0117] Optionally, when the emergency injury and disease drug database has the first key drug sales information, the first key drug sales information of a first preset type number is obtained from the emergency injury and disease drug database and associated with the last column of the data table of the outpatient injury and disease drug database, including:

[0118] When the emergency injury and disease drug database has the first key drug sales information, determining whether the outpatient injury and disease drug database has a free position;

[0119] When the outpatient injury and disease drug database has a vacant position, the first key drug sales information of the first preset type number is obtained from the emergency injury and disease drug database and associated with the last column of the data table of the outpatient injury and disease drug database;

[0120] When the outpatient injury and disease drug database has no free space, determining whether the outpatient injury and disease drug database has deletable drug sales information;

[0121] When the outpatient injury and illness drug database has the deletable drug sales information, the deletable drug sales information is deleted from the outpatient injury and illness drug database, and the first key drug sales information of the first preset type number is obtained from the emergency injury and illness drug database and associated with the last column of the data table of the outpatient injury and illness drug database.

[0122] Optionally, determining whether the outpatient injury and illness drug database contains deletable drug sales information includes:

[0123] Sending a feedback instruction to the first key drug sales information and / or the newly added drug sales information in the outpatient injury and illness drug database;

[0124] If the first key drug sales information and / or the newly added drug sales information does not respond to the feedback instruction within the third preset period, the first key drug sales information and / or the newly added drug sales information that does not respond to the feedback instruction is determined to be deletable drug sales information;

[0125] or;

[0126] If the first key drug sales information and / or the newly added drug sales information cancels the scheduled reading instruction, it is determined that the first key drug sales information and / or the newly added drug sales information that cancels the scheduled reading instruction is deletable drug sales information.

[0127] In a specific implementation manner of the present specification, when there is first key drug sales information in the emergency injury and disease drug database, it is determined whether the outpatient injury and disease drug database has free positions; when the outpatient injury and disease drug database has free positions, the first key drug sales information of the first preset type number is obtained from the emergency injury and disease drug database and is associated with the last column of the data table of the outpatient injury and disease drug database; when the outpatient injury and disease drug database does not have free positions, it is determined whether there is deletable drug sales information in the outpatient injury and disease drug database; a feedback instruction is sent to the first key drug sales information and / or the newly added drug sales information in the outpatient injury and disease drug database; if the first key drug sales information and / or the newly added drug sales information does not respond to the feedback instruction within a third preset period, it is determined that the first key drug sales information and / or the newly added drug sales information that does not respond to the feedback instruction is deletable drug sales information; or; if the first key drug sales information and / or the newly added drug sales information cancel the timed reading instruction, it is determined that the first key drug sales information and / or the newly added drug sales information that cancels the timed reading instruction is deletable drug sales information. When there is deletable drug sales information in the outpatient injury and disease drug database, the deletable drug sales information is deleted from the outpatient injury and disease drug database, and the first key drug sales information of the first preset type number is obtained from the emergency injury and disease drug database and associated with the last column of the data table of the outpatient injury and disease drug database. For example: the capacity of the main drug sales information is 30, the number of current drug sales information types in the outpatient injury and disease drug database is 20, and the outpatient injury and disease drug database has 10 free positions for drug sales information. The first key drug sales information of no more than 10 is obtained from the emergency injury and disease drug database and associated with the outpatient injury and disease drug database. When the current number of drug sales information types in the outpatient injury and disease drug database is 30, the outpatient injury and disease drug database does not have a free position for drug sales information, and a feedback instruction is sent to the first key drug sales information and / or newly added drug sales information in the outpatient injury and disease drug database. Within 10 minutes, 7 first key drug sales information and / or newly added drug sales information do not respond to the feedback instruction, indicating that these 7 first key drug sales information and / or newly added drug sales information are not ready for drug sales information reading, that is, they are deletable drug sales information, and the 7 first key drug sales information and / or newly added drug sales information that have not been fed back can be directly deleted. Alternatively, the 7 first key drug sales information and / or newly added drug sales information actively cancel the scheduled reading instruction, and the revoked 7 first key drug sales information and / or newly added drug sales information are removed from the entire drug sales information scheduling system. At this time, the outpatient injury and disease drug database clears out 7 free positions for drug sales information, and obtains no more than 7 first key drug sales information from the emergency injury and disease drug database to associate with the outpatient injury and disease drug database. This step improves the work efficiency of the system and resource utilization.

[0128] In this embodiment, an emergency green channel information management system is provided. Figure 2 is a schematic diagram of the structure of an emergency green channel information management system according to an embodiment of the present invention. Figure 2 As shown, the system includes the following structure:

[0129] Configuration device 201, used to configure outpatient injury and disease drug database and emergency injury and disease drug database;

[0130] The first acquisition means 202 is used to acquire a timed reading instruction of drug sales information and associate the drug sales information with an emergency injury and disease drug database;

[0131] The first search means 203 is used to search the emergency injury and disease drug database for first key drug sales information according to a first preset period, wherein the first key drug sales information includes the drug sales information in the emergency injury and disease drug database that meets the first preset relationship;

[0132] The first analyzing means 204 is used for obtaining the first preset number of first key drug sales information from the emergency injury and disease drug database and associating the last column of the data table of the outpatient injury and disease drug database with the first key drug sales information when the emergency injury and disease drug database has the first key drug sales information;

[0133] The second search means 205 is used to search the outpatient injury and disease medicine database for second key drug sales information according to a second preset period, wherein the second key drug sales information includes the first key drug sales information in the outpatient injury and disease medicine database that meets the second preset relationship;

[0134] The second analyzing device 206 is used for giving an early warning of the second key drug sales information of a second preset type in the outpatient injury and disease drug database when the outpatient injury and disease drug database contains the second key drug sales information.

[0135] Optionally, the first acquisition device includes:

[0136] A first acquisition module, used for acquiring a timing reading instruction of the drug sales information;

[0137] A first sales analysis module, configured to perform sales analysis on the drug sales information based on the timing information of the drug sales information in the emergency injury and disease drug database, and obtain the popularity of the drug sales information in the emergency injury and disease drug database;

[0138] The first placement module is used to associate the drug sales information with the corresponding heat in the emergency injury and illness drug database.

[0139] Optionally, the system further includes:

[0140] The second acquisition device is used to obtain a read instruction for newly added drug sales information, and associate the newly added drug sales information with an outpatient injury and disease drug database;

[0141] A third search device is used to search the outpatient injury and disease drug database for the second key drug sales information according to the second preset period, wherein the second key drug sales information also includes the newly added drug sales information in the outpatient injury and disease drug database that meets the second preset relationship;

[0142] The third analyzing device is used for giving an early warning of the second key drug sales information of a second preset type number in the outpatient injury and disease drug database when the second key drug sales information is present in the outpatient injury and disease drug database.

[0143] Optionally, the second acquisition device includes:

[0144] A second acquisition module, used for acquiring a reading instruction of the newly added drug sales information;

[0145] A second sales analysis module is used to perform sales analysis on the newly added drug sales information based on the timing information of the first key drug sales information in the outpatient injury and disease drug database to obtain the popularity of the newly added drug sales information in the outpatient injury and disease drug database;

[0146] The second placement module is used to associate the newly added drug sales information with the corresponding popularity in the outpatient injury and illness drug database.

[0147] Optionally, the third analysis device comprises:

[0148] A first decision module is used to decide whether the warning is excessively issued when the outpatient injury and disease drug database contains the second key drug sales information;

[0149] A second decision module is used for obtaining the number of types of warning schemes to be issued for the warning when the warning is not over-issued, and deciding whether the second preset number of types is greater than the number of types of warning schemes to be issued;

[0150] A first issuing module, configured to issue an early warning of the sales information of the second key drugs of the second preset type number in the outpatient injury and disease drug database when the second preset type number is not greater than the type number of the early warning scheme to be issued;

[0151] The second publishing module is used to set the second preset type number to be the same as the number of warning scheme types to be issued when the second preset type number is greater than the number of warning scheme types to be issued, and to give a sales information warning of the second key drug of the second preset type number set in the outpatient injury and illness drug database.

[0152] Optionally, the first analysis device comprises:

[0153] A third decision module is used to decide whether the outpatient injury and disease drug database has a vacant position when the emergency injury and disease drug database has the first key drug sales information;

[0154] A first analysis module is used for obtaining the first key drug sales information of the first preset type number from the emergency injury and disease drug database and associating it with the last column of the data table of the outpatient injury and disease drug database when the outpatient injury and disease drug database has a vacant position;

[0155] A fourth decision module, for deciding whether there is deletable drug sales information in the outpatient injury and disease drug database when the outpatient injury and disease drug database does not have any free space;

[0156] The second analysis module is used for deleting the deletable drug sales information from the outpatient injury and disease drug database when the outpatient injury and disease drug database has the deletable drug sales information, and obtaining the first key drug sales information of the first preset type number from the emergency injury and disease drug database and associating it with the last column of the data table of the outpatient injury and disease drug database.

[0157] Optionally, the fourth decision module includes:

[0158] Sending a feedback instruction to the first key drug sales information and / or the newly added drug sales information in the outpatient injury and illness drug database;

[0159] If the first key drug sales information and / or the newly added drug sales information does not respond to the feedback instruction within the third preset period, the first key drug sales information and / or the newly added drug sales information that does not respond to the feedback instruction is determined to be deletable drug sales information;

[0160] or;

[0161] If the first key drug sales information and / or the newly added drug sales information cancels the scheduled reading instruction, it is determined that the first key drug sales information and / or the newly added drug sales information that cancels the scheduled reading instruction is deletable drug sales information.

[0162] The functions of the system of the embodiment of the present invention have been described in the above method embodiment, so for details not fully described in this embodiment, please refer to the relevant description in the above embodiment, and no further description will be given here.

[0163] In the several embodiments provided in the present application, it should be understood that the disclosed systems, devices and methods can be implemented in other ways. For example, the device embodiments described above are only schematic. For example, the division of modules is only a logical function division. There may be other division methods in actual implementation. For example, multiple modules or components can be combined or integrated into another system, or some features can be ignored or not read. Another point is that the mutual coupling or direct coupling or communication connection shown or discussed can be an indirect coupling or communication connection through some interfaces, devices or modules, which can be electrical, mechanical or other forms.

[0164] In addition, each functional module in each embodiment of the present application can be integrated into a processing module, or each module can be physically provided separately, or two or more modules can be integrated into one module. The above integrated modules can be implemented in the form of hardware or in the form of software functional modules. The above is only an implementation method of the present application, and does not limit the patent scope of the present application. Any equivalent structure or equivalent process transformation made using the content of the specification and drawings of this application, or directly or indirectly used in other related technical fields, is also included in the patent protection scope of the present application.

[0165] The specific implementation methods of the invention are described in detail above, but they are only examples, and the present application is not limited to the specific implementation methods described above. For those skilled in the art, any equivalent modification or substitution of the invention is also within the scope of the present application, and therefore, the equalization, modification, and improvement made without departing from the spirit and principle of the present application should be included in the scope of the present application.

Claims

1. Emergency green channel information management method, It is characterized in that include: Configure outpatient injury and disease drug database and emergency injury and disease drug database; Obtaining a timed reading instruction for drug sales information, and associating the drug sales information with an emergency injury and disease drug database; Searching the emergency disease and injury drug database for first key drug sales information according to a first preset period, wherein the first key drug sales information includes the drug sales information in the emergency disease and injury drug database that meets the first preset relationship; When the emergency disease and injury drug database has the first key drug sales information, the first key drug sales information of a first preset type number is obtained from the emergency disease and injury drug database and associated with the last column of the data table of the outpatient disease and injury drug database; Searching the outpatient injury and disease drug database for second key drug sales information according to a second preset period, wherein the second key drug sales information includes the first key drug sales information in the outpatient injury and disease drug database that meets the second preset relationship; When the outpatient injury and disease drug database has the second key drug sales information, an early warning of the second key drug sales information of a second preset type number in the outpatient injury and disease drug database is given; When the outpatient injury and disease drug database contains the second key drug sales information, giving an early warning of the second key drug sales information of a second preset type in the outpatient injury and disease drug database includes: When the outpatient injury and illness drug database contains the second key drug sales information, determining whether the warning is excessively issued; When the warning is not over-issued, obtaining the number of warning scheme types to be issued for the warning, and determining whether the second preset number of types is greater than the number of warning scheme types to be issued; When the second preset type number is not greater than the number of types of the to-be-issued warning schemes, a warning is given for the sales information of the second key drugs of the second preset type number in the outpatient injury and disease drug database; When the second preset type number is greater than the number of types of the warning schemes to be issued, the second preset type number is set to be the same as the number of types of the warning schemes to be issued, and a warning is given to the second key drug sales information of the second preset type number set in the outpatient injury and disease drug database; When the emergency injury and disease drug database has the first key drug sales information, the first preset type number of the first key drug sales information is obtained from the emergency injury and disease drug database and the last column of the data table associated with the outpatient injury and disease drug database includes: When the emergency injury and disease drug database has the first key drug sales information, determining whether the outpatient injury and disease drug database has a free position; When the outpatient injury and disease drug database has a vacant position, the first key drug sales information of the first preset type number is obtained from the emergency injury and disease drug database and associated with the last column of the data table of the outpatient injury and disease drug database; When the outpatient injury and disease drug database has no free space, determining whether the outpatient injury and disease drug database has deletable drug sales information; When the outpatient injury and illness drug database has the deletable drug sales information, the deletable drug sales information is deleted from the outpatient injury and illness drug database, and the first key drug sales information of the first preset type number is obtained from the emergency injury and illness drug database and associated with the last column of the data table of the outpatient injury and illness drug database.

2. The emergency green channel information management method according to claim 1, It is characterized in that The timed reading instruction for obtaining drug sales information, and associating the drug sales information with an emergency injury and disease drug database, includes: Obtaining a timed reading instruction for the drug sales information; Performing sales volume analysis on the drug sales information based on the timing information of the drug sales information in the emergency injury and disease drug database to obtain the popularity of the drug sales information in the emergency injury and disease drug database; The drug sales information is associated with the corresponding popularity in the emergency injury and illness drug database.

3. The emergency green channel information management method according to claim 1 or 2, It is characterized in that Also includes: Obtaining a read instruction for newly added drug sales information, and associating the newly added drug sales information with an outpatient injury and disease drug database; Searching the outpatient injury and disease drug database for the second preset period to determine whether the second key drug sales information exists, wherein the second key drug sales information also includes the newly added drug sales information in the outpatient injury and disease drug database that meets the second preset relationship; When the outpatient injury and disease drug database has the second key drug sales information, an early warning of the second key drug sales information of a second preset type number in the outpatient injury and disease drug database is given; The instruction to obtain the newly added drug sales information and associate the newly added drug sales information with the outpatient injury and disease drug database includes: Obtaining a read instruction for the newly added drug sales information; Based on the timing information of the first key drug sales information in the outpatient injury and disease drug database, the sales volume of the newly added drug sales information is analyzed to obtain the popularity of the newly added drug sales information in the outpatient injury and disease drug database; The newly added drug sales information is associated with the corresponding popularity in the outpatient injury and illness drug database.

4. The emergency green channel information management method according to claim 1, It is characterized in that The decision as to whether the outpatient injury and illness drug database contains deletable drug sales information includes: Sending a feedback instruction to the first key drug sales information and / or the newly added drug sales information in the outpatient injury and illness drug database; If the first key drug sales information and / or the newly added drug sales information does not respond to the feedback instruction within the third preset period, the first key drug sales information and / or the newly added drug sales information that does not respond to the feedback instruction is determined to be deletable drug sales information; or; If the first key drug sales information and / or the newly added drug sales information cancels the scheduled reading instruction, it is determined that the first key drug sales information and / or the newly added drug sales information that cancels the scheduled reading instruction is deletable drug sales information.

5. Emergency green channel information management system, It is characterized in that include: Configuration device, used for configuring outpatient injury and disease drug database and emergency injury and disease drug database; The first acquisition means is used to acquire a timed reading instruction of drug sales information, and associate the drug sales information with an emergency injury and disease drug database; The first search device is used to search the emergency injury and disease drug database for first key drug sales information according to a first preset period, wherein the first key drug sales information includes the drug sales information in the emergency injury and disease drug database that meets the first preset relationship; The first analyzing means is used for obtaining the first preset number of types of the first key drug sales information from the emergency injury and disease drug database and associating the last column of the data table of the outpatient injury and disease drug database when the emergency injury and disease drug database has the first key drug sales information; The second search device is used to search the outpatient injury and disease drug database for second key drug sales information according to a second preset period, wherein the second key drug sales information includes the first key drug sales information in the outpatient injury and disease drug database that meets the second preset relationship; The second analyzing means is used to give an early warning of the sales information of the second key drugs of a second preset type in the outpatient injury and disease drug database when the sales information of the second key drugs is present in the outpatient injury and disease drug database; The first acquisition device comprises: A first acquisition module, used for acquiring a timing reading instruction of the drug sales information; A first sales analysis module, configured to perform sales analysis on the drug sales information based on the timing information of the drug sales information in the emergency injury and disease drug database, and obtain the popularity of the drug sales information in the emergency injury and disease drug database; A first placement module is used to associate the drug sales information with the corresponding popularity in the emergency injury and disease drug database; Also includes: The second acquisition device is used to obtain a read instruction for newly added drug sales information, and associate the newly added drug sales information with an outpatient injury and disease drug database; A third search device is used to search the outpatient injury and disease drug database for the second key drug sales information according to the second preset period, wherein the second key drug sales information also includes the newly added drug sales information in the outpatient injury and disease drug database that meets the second preset relationship; The third analysis device is used to give an early warning of the sales information of the second key drugs of a second preset type in the outpatient injury and disease drug database when the sales information of the second key drugs is present in the outpatient injury and disease drug database; The second acquisition device comprises: A second acquisition module, used for acquiring a reading instruction of the newly added drug sales information; A second sales analysis module is used to perform sales analysis on the newly added drug sales information based on the timing information of the first key drug sales information in the outpatient injury and disease drug database to obtain the popularity of the newly added drug sales information in the outpatient injury and disease drug database; The second placement module is used to associate the newly added drug sales information with the corresponding popularity in the outpatient injury and disease drug database; The third analysis device comprises: A first decision module is used to decide whether the warning is excessively issued when the outpatient injury and disease drug database contains the second key drug sales information; A second decision module is used for obtaining the number of types of warning schemes to be issued for the warning when the warning is not over-issued, and deciding whether the second preset number of types is greater than the number of types of warning schemes to be issued; A first issuing module, configured to issue an early warning of the sales information of the second key drugs of the second preset type number in the outpatient injury and disease drug database when the second preset type number is not greater than the type number of the early warning scheme to be issued; A second issuing module is used for setting the second preset type number to be the same as the number of the warning scheme types to be issued when the second preset type number is greater than the number of the warning scheme types to be issued, and giving a warning of the sales information of the second key drug of the second preset type number set in the outpatient injury and disease drug database; The first analysis device comprises: A third decision module is used to decide whether the outpatient injury and disease drug database has a vacant position when the emergency injury and disease drug database has the first key drug sales information; A first analysis module is used for obtaining the first key drug sales information of the first preset type number from the emergency injury and disease drug database and associating it with the last column of the data table of the outpatient injury and disease drug database when the outpatient injury and disease drug database has a vacant position; A fourth decision module, for deciding whether there is deletable drug sales information in the outpatient injury and disease drug database when the outpatient injury and disease drug database does not have any free space; The second analysis module is used for deleting the deletable drug sales information from the outpatient injury and disease drug database when the outpatient injury and disease drug database has the deletable drug sales information, and obtaining the first key drug sales information of the first preset type number from the emergency injury and disease drug database and associating it with the last column of the data table of the outpatient injury and disease drug database; The fourth decision module comprises: Sending a feedback instruction to the first key drug sales information and / or the newly added drug sales information in the outpatient injury and illness drug database; If the first key drug sales information and / or the newly added drug sales information does not respond to the feedback instruction within the third preset period, the first key drug sales information and / or the newly added drug sales information that does not respond to the feedback instruction is determined to be deletable drug sales information; or; If the first key drug sales information and / or the newly added drug sales information cancels the scheduled reading instruction, it is determined that the first key drug sales information and / or the newly added drug sales information that cancels the scheduled reading instruction is deletable drug sales information.

Images